February 2021 ICOC Scientific Strategy Advisory Panel
Return to CIRM Meetings and Events
MEETING NOTICE AND AGENDA
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE AND
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
Date: February 22, 2021
Time: 7:00 am to 12:45 pm
Pursuant to Executive Order N-29-20, certain provisions of the Bagley-Keene Open Meeting Act are suspended due to a State of Emergency in response to the COVID-19 pandemic. Consistent with the Executive Order, the meeting of the Independent Citizens Oversight Committee will be conducted by teleconference only. None of the locations from which board members will participate will be open to the public. Members of the public who wish to listen to the meeting may do so via telephone by dialing the number listed below. Members of the public who wish to comment during the meeting may do so by telephone or email, as described below.
Public Comment Instructions
Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following:
- Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment
- Once we call your name you will have 3 Minutes to make your public comment; please remember to be respectful of the time limit.
- Written comment may be sent to the following email address: kmccormack@cirm.ca.gov.
Please click the link below to join the webinar:
https://cirm-ca.zoom.us/j/91736238174?pwd=ZDIzWGcwWFNud1E1cUlDaERqM09XZz09
Passcode: 576401
Dial-In information:
- Dial in number: 1-669-900-6833
- Webinar ID: 917 3623 8174
- Passcode: 576401
Advisory Panel Members
- Chris Austin – Director of the National Center for Advancing Translational Sciences (NCATS) at the NIH
- George Daley – Harvard Stem Cell Biologist and Dean of the Harvard Medical School
- Peter Marks – Director of FDA-CBER
- Victor Dzau – President of the National Academy of Medicine
- Kevin Eggan – Harvard stem cell biologist and Director of Stem Cell Biology at the Broad’s Stanley Center for Psychiatric Research
- Mike McCun – Senior Advisor for Global Health, Gates Foundation
- Christine Mummery – Professor of Developmental Biology at Leiden University Medical Center, Netherlands and President of the International Society for Stem Cell Research (ISSCR)
- Bob Nelsen – Co-Founder and Managing Director of ARCH Venture Partners
- Derrick Rossi – former CIRM Scholar, co-founder of Moderna and CEO Convelo Therapeutics
- Josh Sanes – Harvard neurobiologist and Professor of Molecular and Cellular Biology
- Ilyas Singeç – Director, NCATS Stem Cell Translation Laboratory
- Sally Temple – Founder, Neural Stem Cell Institute, Professor SUNY Albany
- Amy Wagers – Co-Chair of the Harvard Department of Stem Cell and Regenerative Biology
- Fiona Watt – Director of the Centre for Stem Cells & Regenerative Medicine at King’s College London and Executive Chair of the UK Medical Research Council (MRC)
Open Session
- Call to Order.
- Roll Call
Discussion Items
- Presentations to the Scientific Strategy Advisory Panel:
10 Min |
7:00-7:10 |
Jonathan Thomas, Ph.D. CIRM |
Intro to CIRM & Purpose |
10 Min |
7:10-7:20 |
Maria Millan, M.D. CIRM |
|
15 min |
7:20-7:35 |
Gil Sambrano, Ph.D. CIRM |
|
5 Min. |
7:35-7:40 |
Panel |
Questions |
15 Min |
7:40-7:55 |
Amander Clark, Ph.D. UCLA |
Needs in Basic research for ESC, iPSC Tech, & CNS Research |
15 Min |
7:55-8:10 |
Panel |
Discussion |
15 Min |
8:10-8:25 |
Clive Svendsen, Ph.D. Cedars-Sinai |
iPSC Tech for Therapeutic Development and Role of Academic GMP Facilities |
15 Min |
8:25-8:40 |
Panel |
Discussion |
10 Min |
8:40-8:50 |
Claire Henchcliffe, M.D., Ph.D. UC Irvine |
ESC and iPSC for Parkinson’s. Infrastructure Needs; Value of Networks |
15 Min |
8:50-9:05 |
Panel |
Discussion |
15 Min |
9:05-9:20 |
Leslie Thompson, Ph.D. UC Irvine |
Translational research for Neurodegenerative Disease. Role of natural history studies and lessons learned form the Answer ALS Consortium |
15 Min |
9:20-9:35 |
Panel |
Discussion |
10 Min |
9:35-9:45 |
Patrik Brundin, M.D., Ph.D. Van Andel Institute |
New Paradigms for CNS research |
15 Min |
9:45-10:00 |
Panel |
Discussion |
15 min |
10:00-10:15 |
BREAK |
|
10 Min |
10:15-10:25 |
Doug Kerr, M.D., PhD., M.B.A. Generation Bio |
Industry Perspective: why so few products for CNS/rare dis; Gene therapy for CNS |
15 Min |
10:25-10:40 |
Panel |
Discussion |
15 Min |
10:40-10:55 |
Fyodor Urnov, Ph.D. UC Berkeley |
Equitable Access to CRISPR-Cas Treatments for Severe Disease |
15 Min |
10:55-11:10 |
Panel |
Discussion |
15 Min |
11:10-11:25 |
David Haussler, Ph.D. UC Santa Cruz |
|
15 Min |
11:25-11:40 |
Panel |
Discussion |
10 Min |
11:40-11:50 |
Pete Schultz, Ph.D. Scripps |
Small molecule for Regenerative Medicine |
15 Min |
11:50-12:05 |
Panel |
Discussion |
10 Min |
12:05-12:15 |
Cat Jamieson, M.D., Ph.D. UC San Diego |
Regenerative Medicine Approaches for Cancer; Alpha Clinics Network |
15 Min |
12:15-12:30 |
Panel |
Discussion |
- Public comment.
- Adjournment.
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
**NOTICE**
The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 510-340-9111 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 510-340-9111.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.
Last Modified: March 2, 2021